Navigation Links
Novavax CEO to Present at Piper Jaffray 20th Annual Healthcare Conference
Date:12/1/2008

ROCKVILLE, Md., Dec. 1 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Piper Jaffray 20th Annual Healthcare Conference at 11:00 a.m. (EST) on December 2, 2008 in New York. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com under the Investor/Events. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference
2. Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call
3. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
4. Novavax CEO to Present at BIO Investor Forum 2008
5. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
6. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
7. Novavax Announces Closing of $18 Million Registered Direct Offering
8. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
9. Novavax to Join Russell 3000 Index
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Why King Kong failed to impress 2Rodent smoke screen 2ISWA calls attention to important contribution of waste sector to reduce substantial CO2 emissions 2Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 1Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 2Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 3Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 4Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 5Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 6Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 7Let Water Be Water LLC Announces Results of the WAT AAH 21 Challenge 48322 1Let Water Be Water LLC Announces Results of the WAT AAH 21 Challenge 48322 2HealthCore Invites Community based Practitioners to Participate in Real world Research Network 48319 1HealthCore Invites Community based Practitioners to Participate in Real world Research Network 48319 2HealthCore Invites Community based Practitioners to Participate in Real world Research Network 48319 3HealthCore Invites Community based Practitioners to Participate in Real world Research Network 48319 4